Lavalle VA, Flores NG, Solares PM, Pérez BMM, Marco Fuente TMA

Language: Spanish
References: 15
Page: 221-225
PDF size: 135.67 Kb.

ABSTRACT

Objective. To know if the factors associated to the retinopathy of prematurity (ROP) are the same reported by others.
Material and methods. To groups of premature infants ‹ 1,500 g were compared: 16 with ROP and 41 without ROP. All of them were treated in the neonatal intensive care unit (NICU) and they were closely examinated by an ophthalmology since the 3rd week of life. Clinical variables and therapeutic interventions done in both groups were compared.
Results. In the group 16 with ROP, in 8 of them the ROP was grade I; there was 2 neonates with grade II, 4 with grade III and 2 grade V. There were statistical differences in body weight (with ROP: 1,235 ± 156 g, without ROP: 1,347 ± 149 g), gestation age, days with ventilation, days of stay in the NICU, hospital stay, total parental nutrition (TPN) and red cell package transfusion.
Conclusions. The risk was higher in those of smaller gestation age and body weight at birth. They also had more days with ventilation and days the NICU. The results are similar to others reported.

REFERENCES

1. Kinsey VE, Jacobus JT, Hemphill F. Retrolental fibroplasia: cooperative study of retrolental fibroplasia and the use of oxygen. Arch Ophthalmol 1956; 56: 481-7.

2. Phelps DL. Retinopathy of prematurity: A practical clinical approach. NeoReviews 2001; 2: c174-c9.

3. The Committee for the classification of retinopathy of prematurity. An international classification for the retinopathy. Arch Ophthalmol 1984; 102: 1130-4.

4. The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethershold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial, I. Primary outcomes. Pediatrics 2000; 105: 295-10.

5. Lloyd J, Askie L, Smith J, Tarnow-Mordi W. Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity. Cochrane Database Sys Rev 2003; 2: CD003482.

6. Olea VJL, Corretger RFJ, Salvat SM, Frau RE, Galiana FC, Fiol JM. Factores de riesgo en la retinopatía de la prematuridad. An Esp Pediatr 1997; 47: 172-6.

7. Grunauer N, Iriondo SM, Serra CA, Krauel VJ, Jiménez GR. Retinopatía del prematuro. Casuística de los años 1995-2001. An Pediatr (Barc) 2003; 58: 471-7.

8. Fierson WM, Palmer EA, Biglan AW, Flynn JT, Petersen RA, Phelps DL. Screening examination of premature infants for retinopathy of prematurity – a joint statement of the American academy of pediatrics, the American Association for Pediatric Ophthalmology and strabismus, and the American Academy of Ophthalmology. Pediatrics 1997; 100: 273-4.

9. Glowacka E, Kwinta P, Mitkowska Z, Kobylarz J, Kaminska-Mroczkowska H, Mazurek M et al. Risk factors of retinopathy of prematurity in newborns treated in neonatal intensive care unit of University Children’s Hospital Collegium Medicum Jagiellonian University. Przegl Lek 2002; 59 Suppl 1: 86-90.

10. Kim TI, Sohn J, Pi SY, Yoon YH. Post-natal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol 2004; 18(2): 130-4.

11. Lin HJ, Lin CC, Tsai SW, Lin HC, Su BH. Risk factors for retinopathy of prematurity in very low birth-weight infants. J Chin Med Assoc 2003; 66(11): 662-8.

12. Dutta S, Narang S, Narang A, Dogra M, Gupta A. Risk factors of threshold retinopathy of prematurity. Indian Pediatr 2004; 41(7): 665-71.

13. Ikeda H, Kuriyama S. Risk factors for retinopathy of prematurity requiring photocoagulation. Jpn J Ophthalmol 2004; 48(1): 68-71.

14. Gleissner MW, Spantzel T, Bucker-Nott HJ, Jorch G. Risk factors of retinopathy of prematurity in infants 32 to 36 weeks gestational age. Z Geburshilfe Neonatal 2003; 207: 24-8.

15. Hirano K, Morinobu T, Kim H, Ban R, Ogawa S, Ogihara H, et al. Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants. Arch Dis Child Fetal Neonatal Ed 2001; 84: F188-93.